The First Decade of Menopause: Why the First 10 Years Are Critical for Women’s Health
The first decade following the onset of menopause represents a pivotal window for women’s long-term health and quality of life. According to Dr. Sevgi Selen, an Obstetrics and Gynaecology specialist at Acıbadem Eskişehir Hospital, this first 10 years are a ‘golden period’ for intervention, as the timing of treatment can significantly influence a woman’s trajectory of aging.
Menopause is characterized by a loss of ovarian function, which disrupts the essential balance between estrogen and progesterone. As these hormone levels shift, women grow more susceptible to a wide array of systemic health issues. Dr. Selen notes that this period often brings an increased risk of cardiovascular diseases, cognitive decline and urogenital complaints. There is a heightened concern regarding risks of bone and muscle loss after menopause, as well as the “silent dangers” of increased risks of depression and anxiety.
As life expectancies increase, women are spending more time in the menopausal phase. Coupled with growing responsibilities in professional, family, and social spheres, managing these health challenges has become increasingly complex, making early and effective medical guidance essential for maintaining overall wellness.
The Role of Bioidentical Hormone Therapy
To combat these declines, Dr. Selen advocates for the use of bioidentical hormone therapy during the critical first ten-year window. Bioidentical hormones are defined as those that possess the exact same molecular structure as the hormones naturally produced by the human body.
This targeted approach allows physicians to replace depleted hormones to manage everything from heart and bone health to mental stability and sexual function. The most commonly utilized agents in this therapy include:
- Estradiol
- Progesterone
- Testosterone or DHEA (used in specific necessary cases)
The Importance of Timing
While hormone therapy can offer significant benefits, Dr. Selen warns that the window for starting these treatments is limited. Ideally, therapy should be initiated within the first 10 years following menopause. If this timeframe is exceeded, the treatment may no longer be appropriate for every patient due to an increase in cardiovascular risks.
This emphasis on early intervention underscores a broader effort in menopause management in Eskişehir and beyond, aiming to ensure that women can navigate this transition without compromising their long-term health. By utilizing evidence-based medicine and individualized care, specialists aim to help women make informed decisions about their wellbeing during this transformative life stage.
